This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The median CEO of 231 drug companies analyzed by BioPharma Dive earned 50% more last year than in 2017, a leap that far outpaced the more modest pay gains among employees.
Analysts noted hundreds of wholesale price increases, including dozens by Pfizer. Many checked in around 5%, roughly in line with hikes taken in recent years.
The post Supply chain & logistics innovation among pharmacompanies has dropped off in the last year appeared first on Pharmaceutical Technology. Hoffmann-La Roche Ltd (3 applications), and the United States based Thermo Fisher Scientific Inc (1 applications).
The Institute is now looking for partners in pharmacompanies to pursue further clinical development of the findings. Researchers at the Indian Institute of Science (IISc) have found that picolinic acid, a natural compound produced by mammalian cells, can block several disease-causing viruses such as SARS-CoV-2 and influenza A viruses.
Indian healthcare providers and pharmacompanies pace up their efforts with early detection and research for new medicines to combat the spread of tuberculosis as drug resistance concerns emerge. TB is a significant public health threat, with an estimated 10 million annual cases. India shares the highest TB burden with 2.69
Learn valuable marketing lessons for B2B pharmacompanies by examining successful strategies used in the B2C prescription market, including over-the-counter (OTC) products and interactions with healthcare professionals (HCPs).
to acquire Turkish pharmacompany Gensenta for $135m appeared first on Pharmaceutical Technology. “This acquisition fuels our growth by adding local production capabilities in pharmaceuticals, biosimilar products, and active ingredients to our investment portfolio as well as export competency.”. The post Eczac?ba??
The deal, which has Pfizer paying as much as $70 million, is the latest in a series of moves by big pharmacompanies to forge a stronger position in the world's second-largest drug market.
How pharmacompanies can build mutually beneficial relationships with biotech and digital health start-ups Mike.Hammerton Tue, 08/10/2024 - 10:59 Bookmark this
Medical meetings often feature important clinical trial results, making them barometers of biotech and pharmacompanies' research progress. Here’s a list of conferences to watch in 2025.
The pharmacompany, already partnered with BioNTech on vaccines for COVID-19 and influenza, will pay $225 million upfront to further expand its work with the German biotech.
The price ceiling policy has been in place for more than 20 years, but it has neither been very successful nor free of consequences for pharmacompanies.
tax law changes enacted six years ago slashed large pharmacompanies' rates and saved them billions. Now, a push for an international floor could disrupt their R&D accounting.
The pharmacompany, along with its diabetes drug rivals Novo Nordisk and Sanofi, has long been under pressure over the high cost of insulin — scrutiny that has recently ramped up in the U.S.
Severino left the pharmacompany in April after eight years as its chief scientist and then president. He'll lead Tessera Therapeutics, a well-funded genetic medicine startup.
While the national IT outrage caused by cybersecurity specialist CrowdStrike—and subsequently Microsoft—has grounded airlines and forced cancelations at hospitals, the experience from the meltdown | While the national IT outrage caused by cybersecurity specialist CrowdStrike—and subsequently Microsoft—has grounded airlines and forced cancelations at (..)
Competitive intelligence is a vital tool of the research and analysis toolbox for firms wanting valuable data on their market, competitors and customers
Many pharmacompanies are now using de-identified lab data to identify potential patients and their physicians in time to impact the patient’s treatment plan. In this Q&A, learn how lab data can be used to increase patient access.
The Swiss pharmacompany is the latest large drugmaker to invest big in an experimental heart treatment, after years of prioritizing medicines for cancer and immune diseases.
The pharmacompany terminated a collaboration that could’ve netted the biotech about $350 million. It’s the latest in a string of recent setbacks for microbiome drug developers.
Discover how pharmaceutical companies can leverage digital technologies to accelerate innovation and disrupt the industry. Learn about regulatory considerations and engagement with healthcare professionals (HCPs) for successful digital transformation.
Further, 62% of HCPs said that the most significant area where pharma representatives can add value is, by understanding the needs of HCPs and sharing only relevant content with them to make the interactions more insightful. At the same time, marketing emails are among the top 5 channels used by pharmacompanies to engage HCPs.
Considering the low chances of success, with only 10% of drug candidates making it into clinical development, pharmacompanies must prevent the increased erosion of profit margins. This helps to reduce human error and provide more reliable, replicable results and increase the speed of drug discovery and development processes.
The German pharmacompany has secured an option to acquire Trutino Biosciences, two years after inking a research collaboration with the San Diego drug developer.
The pharmaceutical industry is making significant strides toward sustainability, with companies across the sector implementing various Environmental, Social, and Governance (ESG) initiatives.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content